Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue regeneration, today announced the launch of a preclinical development program for B.R.E.A.S.
Conexeu Sciences Inc. ("Conexeu" or the "Company") , a biotechnology company advancing tissue regeneration, today announced the launch of a preclinical development program for B.R.E.A.S.T.™ ...
Polymer bearings do not operate in isolation. Their performance depends on how bearing materials mating surfaces, housings, ...
Key considerations for a company seeking to resolve mass tort claims under Chapter 11 of the Bankruptcy Code, including ...
Andreas Hemmerle Presse und Medien Fraunhofer IWU. Pultrusion is a fully automated manufacturing process in which fibers are ...
Bernstein 42nd Annual Strategic Decisions Conference May 27, 2026 8:00 AM EDTCompany ParticipantsEnrique Lores - President, ...
The careful selection of energy-efficient components like voltage regulators plays a vital role in reducing energy use of a ...
Fabrum has 20 years of experience with composites in superconductive systems, has proven its patented triple-skin tanks in ...
As artificial intelligence (AI) reshapes higher education, educators and technologists must rely on ACTUAL ...
As the president explodes the nuclear energy regulatory landscape, hungry startups like Valar Atomics are racing to build new reactors as quickly as possible. But speed comes at what cost?
Spiceworks on MSN
Six steps to operationalize AI governance
Most organizations already have some kind of AI policy. It might be a slide deck, a PDF, or a page on the intranet that talks ...
Boeing’s 777X now depends on whether GE Aerospace truly solved the GE9X combustor durability issues threatening long-term airline reliability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results